Search research articles
Contact Us
Filters
Showing results (31-40 of 47) with videos related to
Page
of 5
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
December 3, 2015
Receptor Occupancy of the κ-Opioid Antagonist LY2456302 Measured with Positron Emission Tomography and the Novel Radiotracer 11C-LY2795050
Mika Naganawa, Gemma L Dickinson, Ming-Qiang Zheng, et al.
Annals of Neurology
|
January 19, 2020
Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging
David Matuskey, Sule Tinaz, Kyle C Wilcox, et al.
Alcoholism, Clinical and Experimental Research
|
May 4, 2012
Positron emission tomography shows elevated cannabinoid CB1 receptor binding in men with alcohol dependence
Alexander Neumeister, Marc D Normandin, James W Murrough, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 30, 2020
First-in-Human Assessment of <sup>11</sup>C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer
Mika Naganawa, Nabeel Nabulsi, Shannan Henry, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 5, 2024
Quantitative Accuracy Assessment of the NeuroEXPLORER for Diverse Imaging Applications: Moving Beyond Standard Evaluations
Negar Omidvari, Ekaterina Shanina, Edwin K Leung, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 13, 2021
Imaging Pituitary Vasopressin 1B Receptor in Humans with the PET Radiotracer <sup>11</sup>C-TASP699
Mika Naganawa, Nabeel B Nabulsi, David Matuskey, et al.
EJNMMI Research
|
November 8, 2022
Drug characteristics derived from kinetic modeling: combined <sup>11</sup>C-UCB-J human PET imaging with levetiracetam and brivaracetam occupancy of SV2A
Mika Naganawa, Jean-Dominique Gallezot, Sjoerd J Finnema, et al.
Brain Communications
|
October 21, 2024
Clinical correlates of dopamine transporter availability in cross-sectional and longitudinal studies with [<sup>18</sup>F]FE-PE2I PET: independent validation with new insights
Praveen Honhar, Faranak Ebrahimian Sadabad, Sule Tinaz, et al.
Neuroimage
|
October 15, 2022
Age, gender and body-mass-index relationships with in vivo CB<sub>1</sub> receptor availability in healthy humans measured with [<sup>11</sup>C]OMAR PET
Rajiv Radhakrishnan, Patrick D Worhunsky, Ming-Qiang Zheng, et al.
Physics in Medicine and Biology
|
November 20, 2023
Markerless head motion tracking and event-by-event correction in brain PET
Tianyi Zeng, Yihuan Lu, Weize Jiang, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 47) with videos related to
Sort By:
Page
of 5
The Journal of Pharmacology and Experimental Therapeutics
|
December 3, 2015
Receptor Occupancy of the κ-Opioid Antagonist LY2456302 Measured with Positron Emission Tomography and the Novel Radiotracer 11C-LY2795050
Mika Naganawa, Gemma L Dickinson, Ming-Qiang Zheng, et al.
Annals of Neurology
|
January 19, 2020
Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging
David Matuskey, Sule Tinaz, Kyle C Wilcox, et al.
Alcoholism, Clinical and Experimental Research
|
May 4, 2012
Positron emission tomography shows elevated cannabinoid CB1 receptor binding in men with alcohol dependence
Alexander Neumeister, Marc D Normandin, James W Murrough, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 30, 2020
First-in-Human Assessment of <sup>11</sup>C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer
Mika Naganawa, Nabeel Nabulsi, Shannan Henry, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 5, 2024
Quantitative Accuracy Assessment of the NeuroEXPLORER for Diverse Imaging Applications: Moving Beyond Standard Evaluations
Negar Omidvari, Ekaterina Shanina, Edwin K Leung, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 13, 2021
Imaging Pituitary Vasopressin 1B Receptor in Humans with the PET Radiotracer <sup>11</sup>C-TASP699
Mika Naganawa, Nabeel B Nabulsi, David Matuskey, et al.
EJNMMI Research
|
November 8, 2022
Drug characteristics derived from kinetic modeling: combined <sup>11</sup>C-UCB-J human PET imaging with levetiracetam and brivaracetam occupancy of SV2A
Mika Naganawa, Jean-Dominique Gallezot, Sjoerd J Finnema, et al.
Brain Communications
|
October 21, 2024
Clinical correlates of dopamine transporter availability in cross-sectional and longitudinal studies with [<sup>18</sup>F]FE-PE2I PET: independent validation with new insights
Praveen Honhar, Faranak Ebrahimian Sadabad, Sule Tinaz, et al.
Neuroimage
|
October 15, 2022
Age, gender and body-mass-index relationships with in vivo CB<sub>1</sub> receptor availability in healthy humans measured with [<sup>11</sup>C]OMAR PET
Rajiv Radhakrishnan, Patrick D Worhunsky, Ming-Qiang Zheng, et al.
Physics in Medicine and Biology
|
November 20, 2023
Markerless head motion tracking and event-by-event correction in brain PET
Tianyi Zeng, Yihuan Lu, Weize Jiang, et al.
Page
of 5